Neoadjuvant treatment in non-small-cell lung cancer-the earlier, the better

^*Corresponding author for this work

Research output: Contribution to journal › Research letter

Original language	English
Journal	Memo - Magazine of European Medical Oncology
DOIs	https://doi.org/10.1007/s12254-022-00828-3
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{3b7ca79be88146a8bc03e5e48b2a60e1,

title = "Neoadjuvant treatment in non-small-cell lung cancer-the earlier, the better",

author = "Angelika Terbuch and Gudrun Absenger",

year = "2022",

doi = "10.1007/s12254-022-00828-3",

language = "English",

journal = "Memo - Magazine of European Medical Oncology",

issn = "1865-5041",

publisher = "Springer",

}

TY - JOUR

T1 - Neoadjuvant treatment in non-small-cell lung cancer-the earlier, the better

A2 - Terbuch, Angelika

A2 - Absenger, Gudrun

PY - 2022

Y1 - 2022

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000843955300001

U2 - 10.1007/s12254-022-00828-3

DO - 10.1007/s12254-022-00828-3

M3 - Research letter

SN - 1865-5041

JO - Memo - Magazine of European Medical Oncology

JF - Memo - Magazine of European Medical Oncology

ER -